about
Electroconvulsive therapy in Parkinson's diseaseIndependent Validation of the SEND-PD and Correlation with the MDS-UPDRS Part IA.Change in Motor and Nonmotor Symptoms Severity in a "Real-Life" Cohort of Subjects with Parkinson's Disease.A Polysomnographic Study of Parkinson's Disease Sleep Architecture.Parkinson disease and progressive supranuclear palsy: protein expression in skin.A systematic review and mixed treatment comparison of monotherapy in early Parkinson's disease: implications for Latin America.Frequency and clinical correlates of postural and striatal deformities in Parkinson's disease.The P3a wave: A reliable neurophysiological measure of Parkinson's disease duration and severity.Satisfaction with Life Scale (SLS-6): First validation study in Parkinson's disease population.Self-Perceived Pre-Motor Symptoms Load in Patients with Parkinson's Disease: A Retrospective Study.[Two case studies of hypertrophic cardiomyopathy in Friedreich's ataxia].Association of a history of varicella virus infection with multiple sclerosis.Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications.Low specificity and sensitivity of smell identification testing for the diagnosis of Parkinson's disease.Clinical determinants of health-related quality of life in Mexican patients with Parkinson's disease.Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).Comparing the accuracy of different smell identification tests in Parkinson's disease: relevance of cultural aspects.Treatable inherited rare movement disorders.Impact of Neuropsychiatric Symptoms on the Quality of Life of Subjects with Parkinson's Disease.Who Can Diagnose Parkinson's Disease First? Role of Pre-motor Symptoms.Premotor symptoms and the risk of Parkinson's disease: A case-control study in Mexican population.Apathy and associated factors in Mexican patients with Parkinson's disease.Prevalence and correlates of sleep disorders in Parkinson's disease: a polysomnographic study.Convergent validation of EQ-5D-5L in patients with Parkinson's disease.Factors associated with the quality of life of subjects with Parkinson's disease and burden on their caregivers.Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.Pan-American Consortium of Multiple System Atrophy (PANMSA). A Pan-American multicentre cohort study of multiple system atrophy.Impulse control and related disorders in Mexican Parkinson's disease patients.Relationship between the type and side of motor symptoms with the prevalence of non-motor symptoms in Parkinson's disease.Prevalence and determinants of depression in Mexican patients with Parkinson's disease.High frequency of Parkin exon rearrangements in Mexican-mestizo patients with early-onset Parkinson's disease.[Premotor diagnosis of Parkinson's disease].Beta-propeller-associated neurodegeneration can present with dominant or isolated parkinsonism.A reappraisal of the ten steps test for identifying atypical parkinsonism.Association of polymorphisms and reduced expression levels of the NR4A2 gene with Parkinson's disease in a Mexican population.Caffeine drinking, cigarette smoking, and dopaminergic replacement therapy dose in Parkinson's disease.A prospective series of patients with hyperglycaemia-associated movement disorders.Cardiovascular variability in Mexican patients with Parkinson's disease.
P50
Q26786623-40AE89A5-B5F2-4167-91F2-17BE5694F4D2Q34481209-960F5636-194E-4507-96E4-AB18F8B09CD5Q36022124-A1520A9D-AE2E-4705-88CB-91DDF7FCDE03Q36173257-EB4BFD51-0B7B-481A-A143-DC0A51AEB9CEQ36639646-FE0F7290-D9F0-43EA-866B-B206C40C01DFQ38687026-EA960A75-9873-4A6F-9107-D67F84E02DFDQ40005018-915E27AE-BA8B-4288-9DFF-AED81144C574Q40255293-65551D25-5C1E-4A13-A1CF-3C9FC6371501Q40893977-D8BBBAD1-1C15-49EE-9F7D-BEB63A949867Q41037503-6EC59C66-50D0-4B49-830E-753353F0EFA8Q43194738-A18D1556-8C03-482D-8A5B-B7A2D8B7FF2BQ44038871-4EA41166-E3E3-44E0-A012-8A7894E003CCQ44094990-1EE35291-C5E8-435A-8931-2E5F4B192BE8Q44698182-B9A17692-4E4F-42D2-813D-029D6EBCD626Q45358322-15955841-8559-4283-9657-ECAB3A27AF91Q45697484-E166EB63-0402-4988-992D-57FB09E4FA06Q46354756-93BDBA5C-0429-42ED-B0FA-994A300608EAQ47301574-8D7D2AF3-1C39-49E7-A763-C287F6673C08Q47625425-B21B26D0-0F97-45E5-8114-12C6FCEE70C5Q47631805-607EF76B-ED05-4881-8BFD-BB5649F2287AQ47640955-3A7C3045-DE95-4AE7-9B4D-9DC70F94C75AQ47688338-DD9E4D02-69E7-433B-BF11-160652CE16F4Q47717070-AF599A19-3652-4B95-974F-5DCE24C4B0BCQ47948376-B3269F99-6F78-43DB-BE7F-804549711B63Q47985707-EE1BB0DE-A58D-43F8-AFB9-5282618932A8Q47988107-FCCA9134-2877-4785-877E-02A5661ED692Q48080818-E170A259-594A-4144-A356-B7677E015146Q48093163-279F8551-DDC1-4A21-B486-21CE9C99EA66Q48215057-2D87DA4E-11DE-4A0C-BE19-D19506204D04Q48272332-E001A476-58DC-4248-8B17-35F629554454Q48317265-93810C54-83B2-4511-95FC-E86CF8C97D34Q48697786-CC63C529-8A1F-496A-9488-12AEE3474A60Q50254943-3DA6F068-992F-4D36-850B-129A754FA11DQ50265282-12645936-2BA3-4A9C-9D55-E8BA11F88E7FQ50421608-3D3889AB-C834-4C9C-9725-5A915B371F21Q50476590-1C652566-3B1F-4F25-AB31-A901753BE7FCQ50527370-E5751FD3-3274-4C63-87B8-F93B0042C9BEQ50913570-ABCB0114-D973-4764-8397-F7B279BCC732Q51370410-B5739D0A-17ED-4F31-9914-F52A192BD1E8Q51689015-D00EDE43-24BC-479C-97F0-245D1C306CCB
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mayela Rodríguez-Violante
@ast
Mayela Rodríguez-Violante
@en
Mayela Rodríguez-Violante
@es
Mayela Rodríguez-Violante
@nl
Mayela Rodríguez-Violante
@sl
type
label
Mayela Rodríguez-Violante
@ast
Mayela Rodríguez-Violante
@en
Mayela Rodríguez-Violante
@es
Mayela Rodríguez-Violante
@nl
Mayela Rodríguez-Violante
@sl
altLabel
Rodríguez-Violante M
@en
prefLabel
Mayela Rodríguez-Violante
@ast
Mayela Rodríguez-Violante
@en
Mayela Rodríguez-Violante
@es
Mayela Rodríguez-Violante
@nl
Mayela Rodríguez-Violante
@sl
P1053
G-7056-2015
P106
P1153
24482411600
56013663500
P21
P2798
P31
P3829
P3835
mayela-rodriguez-violante
P4012
P496
0000-0002-6041-9941